Stephen J Weiss

9PUBLICATIONS
44CO-AUTHORS
BiomaterialsTissue engineeringHaematological tumoursMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 10, 2026
Amoeboid-mesenchymal transition and the proteolytic control of cancer invasion plasticity.

Adam W Olson, Jonathan Li, Xiao-Yan Li

|Jul 11, 2024
Mmp14-dependent remodeling of the pericellular-dermal collagen interface governs fibroblast survival.

Farideh Sabeh, Xiao-Yan Li, Adam W Olson

|Jul 17, 2023
The checkpoint inhibitor PD-1H/VISTA controls osteoclast-mediated multiple myeloma bone disease.

Jing Fu, Shirong Li, Huihui Ma

|Mar 07, 2023
Proteolytic regulation of a galectin-3/Lrp1 axis controls osteoclast-mediated bone resorption.

Lingxin Zhu, Yi Tang, Xiao-Yan Li

|Feb 27, 2023
A Zeb1/MtCK1 metabolic axis controls osteoclast activation and skeletal remodeling.

Lingxin Zhu, Yi Tang, Xiao-Yan Li

|Dec 21, 2022
Discoidin domain receptor 2 regulates aberrant mesenchymal lineage cell fate and matrix organization.

Chase A Pagani, Alec C Bancroft, Robert J Tower

Pageof 2

Frequent Collaborators

3 joint publications

Lingxin Zhu

3 joint publications

Xiao-Yan Li

2 joint publications

Evan T Keller

2 joint publications

Adam W Olson